Internal Medicine, Gastroenterology · Hemet, CA
NPI
1700803798
Since 2006
Specialty
Internal Medicine, Gastroenterology
Code 207RG0100X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
1003 E Florida Ave, # 101
Hemet, CA, 92543
Phone (951) 652-2252
Groups this clinician bills Medicare through
Medicare paid, 2024
$163K
1,467 services
Medicare patients, 2024
583
Average age 70
Drug cost, 2024
$364K
1,461 prescriptions
Company payments, 2025
$1,680
From 13 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Milan S Chakrabarty was code 99214 (office e&m - established), 683 times for 365 patients. In total Milan S Chakrabarty billed 1,467 services in 19 codes, and Medicare paid $163K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2014-07-29.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 683 | 365 | $101.58 | $69K |
| 99204 Office E&M - New | Office | 257 | 257 | $118.87 | $31K |
| 43239 Upper GI Endoscopy | Facility | 163 | 156 | $110.95 | $18K |
| 45380 Lower GI Endoscopy - Other | Facility | 134 | 131 | $139.62 | $19K |
| 99213 Office E&M - Established | Office | 93 | 70 | $60.94 | $5,667 |
| 43450 Digestive/Gastrointestinal | Facility | 41 | 40 | $33.34 | $1,367 |
| 45385 Colonoscopy - Lesion Removal | Facility | 29 | 28 | $213.97 | $6,205 |
| G0121 Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Facility | 20 | 20 | $186.25 | $3,725 |
| G0121 Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Office | 13 | 13 | $366.53 | $4,765 |
By year: 2022 $112K for 1,135 services; 2023 $139K for 1,300 services; 2024 $163K for 1,467 services.
Medicare prescription drug claims, 2024
In 2024, the drug Milan S Chakrabarty prescribed most often to Medicare patients was Omeprazole, with 332 prescriptions and refills. In total Milan S Chakrabarty wrote 1,461 Medicare prescriptions that cost $364K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Omeprazole Generic | 332 | 778 | 187 | $4,468 |
| Famotidine Generic | 316 | 765 | 185 | $3,713 |
| Linzess Linaclotide | 122 | 148 | 41 | $77K |
| Pantoprazole Sodium Generic | 81 | 154 | 41 | $855 |
| Gavilyte-G Peg3350/Sod Sulf,bicarb,cl/Kcl | 44 | 44 | 42 | $771 |
| Clarithromycin Generic | 29 | 29 | 29 | $630 |
| Metoclopramide Hcl Generic | 25 | 25 | Under 11 | $155 |
| Peg-3350 And Electrolytes Peg3350/Sod Sulf,bicarb,cl/Kcl | 24 | 24 | 24 | $358 |
| Amoxicillin Generic | 22 | 22 | 22 | $99.45 |
| Dexlansoprazole Dr Dexlansoprazole | 20 | 34 | Under 11 | $6,566 |
| Creon Lipase/Protease/Amylase | 20 | 23 | Under 11 | $60K |
| Lansoprazole Generic | 20 | 42 | Under 11 | $328 |
| Dicyclomine Hcl Generic | 20 | 21 | Under 11 | $141 |
| Gavilyte-C Peg3350/Sod Sulf,bicarb,cl/Kcl | 17 | 17 | 17 | $292 |
| Budesonide Dr Budesonide | 17 | 17 | Under 11 | $4,879 |
Brand drugs: 280 claims; generic drugs: 1,181 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Milan S Chakrabarty $1,680 ($1,680 in general payments such as food, travel and fees) from 13 companies. The largest payer was Abbvie Inc. with $543.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 33 | $543 |
| Ardelyx, Inc. ARDX | 12 | $388 |
| Madrigal Pharmaceuticals MDGL | 9 | $355 |
| Phathom Pharmaceuticals, Inc. PHAT | 6 | $78.34 |
| Pfizer Inc. PFE | 3 | $68.44 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC BHC | 3 | $56.08 |
| Janssen Biotech, Inc. JNJ | 2 | $40.96 |
| QOL Medical, LLC | 2 | $37.58 |
| Takeda Pharmaceuticals U.S.A., Inc. TAK | 1 | $32.62 |
| Echosens North America, Inc. | 1 | $24.91 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.